Consequences of Gestational Diabetes in an Urban Hospital in Viet Nam: A Prospective Cohort Study

English version České info

Background:
Gestational diabetes mellitus (GDM) is increasing and is a risk for type 2 diabetes. Evidence supporting screening comes mostly from high-income countries. We aimed to determine prevalence and outcomes in urban Viet Nam. We compared the proposed International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criterion, requiring one positive value on the 75-g glucose tolerance test, to the 2010 American Diabetes Association (ADA) criterion, requiring two positive values.

Methods and Findings:
We conducted a prospective cohort study in Ho Chi Minh City, Viet Nam. Study participants were 2,772 women undergoing routine prenatal care who underwent a 75-g glucose tolerance test and interview around 28 (range 24–32) wk. GDM diagnosed by the ADA criterion was treated by local protocol. Women with GDM by the IADPSG criterion but not the ADA criterion were termed “borderline” and received standard care. 2,702 women (97.5% of cohort) were followed until discharge after delivery. GDM was diagnosed in 164 participants (6.1%) by the ADA criterion, 550 (20.3%) by the IADPSG criterion. Mean body mass index was 20.45 kg/m² in women with out GDM, 21.10 in women with borderline GDM, and 21.81 in women with GDM, p<0.001. Women with GDM and borderline GDM were more likely to deliver preterm, with adjusted odds ratios (aORs) of 1.49 (95% CI 1.16–1.91) and 1.52 (1.03–2.24), respectively. They were more likely to have clinical neonatal hypoglycaemia, aORs of 4.94 (3.41–7.14) and 3.34 (1.41–7.89), respectively. For large for gestational age, the aORs were 1.16 (0.93–1.45) and 1.31 (0.96–1.79), respectively. There was no significant difference in large for gestational age, death, severe birth trauma, or maternal morbidity between the groups. Women with GDM underwent more labour inductions, aOR 1.51 (1.08–2.11).

Conclusions:
Choice of criterion greatly affects GDM prevalence in Viet Nam. Women with GDM by the IADPSG criterion were at risk of preterm delivery and neonatal hypoglycaemia, although this criterion resulted in 20% of pregnant women being positive for GDM. The ability to cope with such a large number of cases and prevent associated adverse outcomes needs to be demonstrated before recommending widespread screening.

Please see later in the article for the Editors' Summary.

Vyšlo v časopise: Consequences of Gestational Diabetes in an Urban Hospital in Viet Nam: A Prospective Cohort Study. PLoS Med 9(7): e32767. doi:10.1371/journal.pmed.1001272
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001272

Souhrn

Zdroje

1. DanaeiG, FinucaneMM, LuY, SinghGM, CowanMJ, et al. (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378: 31–40.

2. BellamyL, CasasJP, HingoraniAD, WilliamsD (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373: 1773–1779.

3. CrowtherCA, HillerJE, MossJR, McPheeAJ, JeffriesWS, et al. (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352: 2477–2486.

4. HAPO Study Cooperative Research Group (2008) MetzgerBE, LoweLP, DyerAR, TrimbleER, et al. (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358: 1991–2002.

5. LandonMB, SpongCY, ThomE, CarpenterMW, RaminSM, et al. (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361: 1339–1348.

6. MetzgerBE, GabbeSG, PerssonB, BuchananTA, CatalanoPA, et al. (2010) International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33: 676–682.

7. BlackwellS (2011) Gestational diabetes—staying with old or marrying new guidelines. Am J Obstet Gynecol 204: 371–372.

8. Tieu J, Middleton P, McPhee AJ, Crowther CA (2010) Screening and subsequent management for gestational diabetes for improving maternal and infant health. Cochrane Database Syst Rev 2010: CD007222.

9. Alwan N, Tuffnell DJ, West J (2009) Treatments for gestational diabetes. Cochrane Database Syst Rev 2009: CD003395.

10. World Bank Bank (2012) GDP per capita (current US$) [database]. Available: http://data.worldbank.org/indicator/NY.GDP.PCAP.CD. Accessed 1 November 2011.

11. TaMT, NguyenKT, NguyenND, CampbellLV, NguyenTV (2010) Identification of undiagnosed type 2 diabetes by systolic blood pressure and waist-to-hip ratio. Diabetologia 53: 2139–2146.

12. HenryOA, BeischerNA, SheedyMT, WalstabJE (1993) Gestational diabetes and follow-up among immigrant Vietnam-born women. Aust N Z J Obstet Gynaecol 33: 109–114.

13. Viet Nam Committee for Population, Family and Children, ORC Macro (2003) Vietnam Demographic and Health Survey 2002. Calverton (Maryland): Viet Nam Committee for Population, Family and Children and ORC Macro.

14. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33 (Suppl 1) S62–S69.

15. World Health Organization (2009) WHO guidelines for the management of postpartum haemorrhage and retained placenta. Available: http://whqlibdoc.who.int/publications/2009/9789241598514_eng.pdf. Accessed 20 June 2012.

16. SchroederB (2002) American College of Obstetricians and Gynecologists (2002) ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. Am Fam Physician 66: 330–331.

17. RoystonP, AltmanDG, SauerbreiW (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25: 127–141.

18. LumbiganonP, LaopaiboonM, GulmezogluAM, SouzaJP, TaneepanichskulS, et al. (2010) Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007–08. Lancet 375: 490–499.

19. RobertsC, LancasterP (1999) Australian national birthweight percentiles by gestational age. Med J Aust 170: 114–118.

20. CatalanoPM, ThomasA, Huston-PresleyL, AminiSB (2003) Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol 189: 1698–1704.

21. OuzounianJG, RosenheckR, LeeRH, YedigarovaL, WaldenCL, et al. (2011) One-hour post-glucola results and pre-pregnancy body mass index are associated with the need for insulin therapy in women with gestational diabetes. J Matern Fetal Neonatal Med 24: 718–722.

22. O'SullivanEP, AvalosG, O'ReillyM, DennedyMC, GaffneyG, et al. (2011) Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia 54: 1670–1675.

23. BanerjeeS, GhoshUS, BanerjeeD (2004) Effect of tight glycaemic control on fetal complications in diabetic pregnancies. J Assoc Physicians India 52: 109–113.

24. HuddleKR (2005) Audit of the outcome of pregnancy in diabetic women in Soweto, South Africa, 1992–2002. S Afr Med J 95: 789–794.

25. HirstJE, ArbuckleSM, DoTM, HaLT, JefferyHE (2010) Epidemiology of stillbirth and strategies for its prevention in Vietnam. Int J Gynaecol Obstet 110: 109–113.

26. WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157–163.

27. GuntonJ, HitchmanR, McElduffA (2001) Effects of ethnicity on glucose tolerance, insulin resistance and beta cell function in 223 women with an abnormal glucose challenge test during pregnancy. Aust N Z J Obstet Gynaecol 41: 182–186.

28. RetnakaranR, HanleyAJ, ConnellyPW, SermerM, ZinmanB (2006) Ethnicity modifies the effect of obesity on insulin resistance in pregnancy: a comparison of Asian, South Asian, and Caucasian women. J Clin Endocrinol Metab 91: 93–97.

29. KimSY, EnglandL, WilsonHG, BishC, SattenGA, et al. (2010) Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am J Public Health 100: 1047–1052.

30. PetryC (2010) Gestational diabetes: risk factors and recent advances in its genetics and treatment. Br J Nutr 104: 775–787.

31. HalesCN, BarkerDJ (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35: 595–601.

32. RomanAS, RebarberA, FoxNS, KlauserCK, IstwanN, et al. (2011) The effect of maternal obesity on pregnancy outcomes in women with gestational diabetes. J Matern Fetal Neonatal Med 24: 723–727.

33. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group (2010) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol 202: 255.e1–255.e7.

34. HunsbergerM, RosenbergKD, DonatelleRJ (2010) Racial/ethnic disparities in gestational diabetes mellitus: findings from a population-based survey. Womens Health Issues 20: 323–328.

35. AnnaV, van der PloegHP, CheungNW, HuxleyRR, BaumanAE (2008) Sociodemographic correlates of the increasing trend in prevalence of gestational diabetes mellitus in a large population of women between 1995 and 2005. Diabetes Care 31: 2288–2293.

36. GongJ, SavitzD, SteinC, EngelS (2012) Maternal ethnicity and pre-eclampsia in New York City, 1995–2003. Paediatr Perinat Epidemiol 26: 45–52.

37. FlackJR, RossGP, HoS, McElduffA (2010) Recommended changes to diagnostic criteria for gestational diabetes: impact on workload. Aust N Z J Obstet Gynaecol 50: 439–443.

38. MorikawaM, YamadaT, AkaishiR, NishidaR, ChoK, et al. (2010) Change in the number of patients after the adoption of IADPSG criteria for hyperglycemia during pregnancy in Japanese women. Diabetes Res Clin Pract 90: 339–342.

39. AgarwalMM, DhattGS, ShahSM (2010) Gestational diabetes mellitus: simplifying the International Association of Diabetes and Pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care 33: 2018–2020.